Fornier M - Search Results

1

Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy.

Foa P, Iurlo A, Orazi A, Saglio G, Ribera S, Bertoni F, Caldiera S, Fornier M, Maiolo AT. Foa P, et al. Among authors: fornier m. Acta Haematol. 1997;97(3):187-8. doi: 10.1159/000203679. Acta Haematol. 1997. PMID: 9066716 No abstract available.

2

Polycythemia vera treated with recombinant interferon-alpha 2a: evidence of a selective effect on the malignant clone.

Massaro P, Foa P, Pomati M, LaTargia ML, Iurlo A, Clerici C, Caldiera S, Fornier M, Maiolo AT. Massaro P, et al. Among authors: fornier m. Am J Hematol. 1997 Oct;56(2):126-8. doi: 10.1002/(sici)1096-8652(199710)56:2<126::aid-ajh10>3.0.co;2-a. Am J Hematol. 1997. PMID: 9326356 Free article.

3

Palmar-plantar erythrodysaesthesia syndrome due to 5-fluorouracil therapy--an underestimated toxic event?

Iurlo A, Fornier M, Caldiera S, Bertoni F, Foa P. Iurlo A, et al. Among authors: fornier m. Acta Oncol. 1997;36(6):653-4. doi: 10.3109/02841869709001331. Acta Oncol. 1997. PMID: 9408159 No abstract available.

4

Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer.

Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Massaron S, Cataldo I, Oldani S, Iurlo A, Caldiera S, Bombardieri E. Foa P, et al. Among authors: fornier m. Int J Biol Markers. 1999 Apr-Jun;14(2):92-8. doi: 10.1177/172460089901400206. Int J Biol Markers. 1999. PMID: 10399628 Free article.

5

Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.

Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E. Foa P, et al. Among authors: fornier m. Anticancer Res. 1999 Jul-Aug;19(4C):3613-8. Anticancer Res. 1999. PMID: 10629660

6

Chronic myeloid leukemia treated with busulfan.

Foa P, Iurlo A, Ribera S, Damilano I, Caldiera S, Fornier M, Bertoni F, Maiolo A. Foa P, et al. Among authors: fornier m. Oncol Rep. 1996 Nov;3(6):1067-9. doi: 10.3892/or.3.6.1067. Oncol Rep. 1996. PMID: 21594509

7

Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera.

Foa P, Massaro P, Caldiera S, LaTargia ML, Iurlo A, Clerici C, Fornier M, Bertoni F, Maiolo AT. Foa P, et al. Among authors: fornier m. Eur J Haematol. 1998 May;60(5):273-7. doi: 10.1111/j.1600-0609.1998.tb01039.x. Eur J Haematol. 1998. PMID: 9654155

8

Fluorescence in situ hybridization (FISH) for evaluating residual disease in Philadelphia chromosome-positive chronic myeloid leukemia during interferon alpha therapy.

Foa P, Pomati M, Ribera S, Caldiera S, Bertoni F, Fornier M, Maiolo A. Foa P, et al. Among authors: fornier m. Oncol Rep. 1996 Sep;3(5):847-9. doi: 10.3892/or.3.5.847. Oncol Rep. 1996. PMID: 21594466

9

Initial chemotherapy for primary resectable large-cell lymphoma of the stomach.

Tondini C, Balzarotti M, Santoro A, Zanini M, Fornier M, Giardini R, Di Felice G, Bozzetti F, Bonadonna G. Tondini C, et al. Among authors: fornier m. Ann Oncol. 1997 May;8(5):497-9. doi: 10.1023/a:1008206329583. Ann Oncol. 1997. PMID: 9233531 Free article.

10

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.

Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, Fornier M, Devizzi L, Verderio P, Valagussa P, Bonadonna G. Viviani S, et al. Among authors: fornier m. Br J Cancer. 1998 Mar;77(6):992-7. doi: 10.1038/bjc.1998.163. Br J Cancer. 1998. PMID: 9528846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters